Expert campus | Perspective on late stage clinical development
Moderation:
- Fiona Marston, Director, Centre of Excellence in Infectious Diseases (CEIDR)
Speakers:
- Sarah Paulin, Technical Officer on Antimicrobial Resistance (AMR), World Health Organization (WHO)
This content has been restricted to logged in users only. Please login to view this content.
- Laurenz Kellenberger – CSO, Basilea
- Patrick Velicitat – CMO, Allecra
This content has been restricted to logged in users only. Please login to view this content.
Play Video
This might also be of interest for you:
- More about the WHO’s antibacterial pipeline reports can be found here
- News release, 11 August, Basilea reports strong financial results for half-year 2020, progress in R&D portfolio and successful completion of strategic projects, despite COVID-19
- News release, 25 February: Allecra Therapeutics Announces Positive Top-Line Results for Phase 3 ALLIUM Clinical Trial of EXBLIFEP® for Complicated Urinary Tract Infections
